Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Monash IVF to acquire 80% of Perth fertility clinic for $12m in expansion bid

  • In News
  • December 19, 2023
  • Alinda Gupta
Monash IVF to acquire 80% of Perth fertility clinic for $12m in expansion bid

Fertility specialists Monash IVF (ASX: MVF) appears to have found fertile ground for growth, as it locks in the acquisition of Perth-based IVF and fertility clinic Fertility North. Fertility North services Perth’s northern suburbs, helping MVF attract new clientele.

Monash IVF will acquire 80% of Fertility North through an initial upfront cash payment estimated at $12 million. Fertility North currently generates around $9 million in annual revenue, and it is expected to contribute to an approximately 4% increase in Monash IVF’s Net Profit After Tax (NPAT) based on Monash IVF’s FY23 Adjusted NPAT, with its reported FY23 NPAT being $22 million.

Additional payments, contingent on meeting specific financial goals, may be made over one to three years. Monash IVF retains the option to acquire the remaining 20% of Fertility North, but this can occur no sooner than three years from the completion of the acquisition.

Monash IVF CEO and Managing Director Michael Knaap said, “We are very excited to be expanding our presence in the fast-growing Perth market through the acquisition of Fertility North. We believe the businesses of Fertility North and our existing Monash IVF business in Perth are complementary to each other, servicing different catchment areas, with Fertility North servicing Perth’s northern suburbs and Monash IVF West Leederville (formerly PIVET Medical Centre) servicing central and southern Perth.”

He added, “The transaction structure mutually aligns Monash IVF and Fertility North to grow the Fertility North business and rewards Fertility North’s shareholders for delivering on its growth targets.”

Founded in 2002 by fertility specialists Dr Vince Chapple (Medical Director) and Dr Jay Natalwala (Clinical Director) in Perth, Fertility North operates from an advanced clinic at Joondalup Health Campus. The clinic encompasses consultation, laboratory facilities, and access to a co-located day surgery. The acquisition of Fertility North will bring eight additional fertility specialists to the Monash IVF Group.

Plus, acquiring Fertility North allows Monash IVF to tap into Perth’s rapidly expanding northern growth corridor, which boasts a growing market. Fertility North’s clinicians and staff focus aligns with the overarching goal of offering patients the best chances for a healthy pregnancy, a commitment reflected in Fertility North’s success rates.

Fertility North co-founder Dr Jay Natalwala commented, “Joining forces with Monash IVF represents the culmination of over 20 years of dedication to building one of Perth’s leading IVF clinics. We could not have achieved this milestone without the amazing team we have built, and we look forward to continuing to support our patients and community as part of the larger Monash IVF Group”.

In FY23, Monash IVF saw its success rates rise by 6.1% compared to 2019. It recorded a revenue of $213.6 million and saw new patient registrations increase by 12% on FY22. The Company made two domestic acquisitions in the period, a nod towards its expansion strategy.  

The Fertility North acquisition is contingent upon meeting specific conditions, notably approval from the Australian Competition and Consumer Commission (ACCC). The acquisition is set to be completed in the third quarter of FY24. 

Funding for the acquisition, covering the initial purchase price and potential subsequent earn-out payments, is anticipated to come from Monash IVF’s operational cash flows and/or accessible debt facilities.

 

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx mvf
  • Fertility North
  • Jay Natalwala
  • michael knaap
  • monash ivf
  • Vince Chapple
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.